262 related articles for article (PubMed ID: 24331208)
1. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.
Scavone M; Germanovich K; Femia EA; Cattaneo M
Thromb Res; 2014 Feb; 133(2):254-6. PubMed ID: 24331208
[TBL] [Abstract][Full Text] [Related]
2. The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y₁₂ receptor inhibition.
Koessler J; Kobsar AL; Rajkovic MS; Schafer A; Flierl U; Pfoertsch S; Bauersachs J; Steigerwald U; Rechner AR; Walter U
Platelets; 2011; 22(1):20-7. PubMed ID: 20873965
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the INNOVANCE PFA P2Y test cartridge: sensitivity to P2Y(12) blockade and influence of anticoagulant.
Edwards A; Jakubowski JA; Rechner AR; Sugidachi A; Harrison P
Platelets; 2012; 23(2):106-15. PubMed ID: 21848368
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the new INNOVANCE® PFA P2Y cartridge in patients with impaired primary haemostasis.
Koessler J; Ehrenschwender M; Kobsar A; Brunner K
Platelets; 2012; 23(8):571-8. PubMed ID: 22185369
[TBL] [Abstract][Full Text] [Related]
5. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance.
Tsantes A; Ikonomidis I; Papadakis I; Kottaridi C; Tsante A; Kalamara E; Kardoulaki A; Kopterides P; Kapsimali V; Karakitsos P; Lekakis J; Travlou A
Platelets; 2012; 23(6):481-9. PubMed ID: 22646492
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system.
Kobsar AL; Koessler J; Rajkovic MS; Brunner KP; Steigerwald U; Walter U
Platelets; 2010; 21(2):112-6. PubMed ID: 20085435
[TBL] [Abstract][Full Text] [Related]
8. Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y.
Linnemann B; Schwonberg J; Rechner AR; Mani H; Lindhoff-Last E
Ann Hematol; 2010 Jun; 89(6):597-605. PubMed ID: 20049442
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
10. Ability of the INNOVANCE PFA P2Y system to detect clopidogrel-induced ADP receptor blockade in preangiocath individuals.
McGlasson DL; Shah AD; Fritsma GA
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):583-7. PubMed ID: 21799401
[TBL] [Abstract][Full Text] [Related]
11. Hemodialysis shortens long in vitro closure times as measured by the PFA-100.
Bilgin AU; Karadogan I; Artac M; Kizilors A; Bligin R; Undar L
Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638
[TBL] [Abstract][Full Text] [Related]
12. The influence of clinical characteristics, laboratory and inflammatory markers on 'high on-treatment platelet reactivity' as measured with different platelet function tests.
Elsenberg EH; van Werkum JW; van de Wal RM; Zomer AC; Bouman HJ; Verheugt FW; Berg JM; Hackeng CM
Thromb Haemost; 2009 Oct; 102(4):719-27. PubMed ID: 19806258
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the INNOVANCE PFA P2Y assay and its association with CYP2C19 genotypes.
Kim H; Kim Y; Koh YS; Lee HK; Chae H; Jekarl DW; Lee JM; Shin WS; Kim TH
Platelets; 2015; 26(2):148-53. PubMed ID: 24617511
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion.
Cattaneo M; Lecchi A; Agati B; Lombardi R; Zighetti ML
Thromb Res; 1999 Nov; 96(3):213-7. PubMed ID: 10588464
[TBL] [Abstract][Full Text] [Related]
15. High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests.
Jover E; Rodríguez JM; Bernal A; Arroyo AB; Iniesta JA; Guiú IS; Martínez C; Vicente V; Lozano ML; Rivera J
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):604-11. PubMed ID: 24717421
[TBL] [Abstract][Full Text] [Related]
16. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.
Haubelt H; Anders C; Vogt A; Hoerdt P; Seyfert UT; Hellstern P
Br J Haematol; 2005 Sep; 130(5):759-67. PubMed ID: 16115134
[TBL] [Abstract][Full Text] [Related]
17. PFA-100 System: A New Method for Assessment of Platelet Dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 2024 Jun; 50(4):664-671. PubMed ID: 38092024
[TBL] [Abstract][Full Text] [Related]
18. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100.
Cesar JM; de Miguel D; García Avello A; Burgaleta C
Am J Clin Pathol; 2005 May; 123(5):772-7. PubMed ID: 15981818
[TBL] [Abstract][Full Text] [Related]
19. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
[TBL] [Abstract][Full Text] [Related]
20. A comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention.
Jang J; Lim J; Chang K; Kim Y; Kim M; Park HI; Kim J; Shin S
J Clin Lab Anal; 2012 Jul; 26(4):262-6. PubMed ID: 22811359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
